Indicator summary: Leaning bearish (2 bullish, 3 bearish, 0 neutral). As of 2026-10-15, the close was $32.87: 12.6% below the 50-day average and 4.6% below the 200-day average, which is falling. RSI (14) is 25, oversold. MACD is bearish. The stock sits 40% of the way up its 52-week range of $27.14 to $41.62, on 1.1x its 20-day average volume.
| Indicator | Reading | Read |
|---|---|---|
| 50-day average | $37.60 | Price 12.6% below |
| 200-day average | $34.45 | Price 4.6% below, average falling |
| 50 vs 200-day | 50 above 200 | Golden-cross alignment |
| RSI (14) | 25 | Oversold |
| MACD (12, 26, 9) | -1.39 vs -1.19 | Line below signal |
| 52-week range | $27.14 to $41.62 | 40% of the way up the range |
| Volume vs 20-day average | 1.1x | Normal |
Base rates use DB's own daily history since 1999; they describe the past, not a forecast.
As of 2026-10-15, DB's 14-day RSI is 25, which is oversold (below 30). When it had RSI below 30 (274 days), it was higher 63 trading days later 54% of the time, median +1.5%.
No. DB closed at $32.87 on 2026-10-15, 4.6% below its 200-day average of $34.45, which is falling. When it closed below its 200-day average (3,078 days), it was higher 63 trading days later 48% of the time, median -0.9%.
No. DB closed at $32.87 on 2026-10-15, 12.6% below its 50-day average of $37.60. When it closed below its 50-day average (3,236 days), it was higher 63 trading days later 51% of the time, median +0.4%.
No cross in the last 10 trading days. As of 2026-10-15 the MACD line is -1.39 against a signal line of -1.19, so MACD is bearish.
No. At $32.87 it sits 40% of the way up its 52-week range of $27.14 to $41.62, 21.0% below the high.
Leaning bearish: 2 of 5 indicators are bullish and 3 bearish as of 2026-10-15 (the 50 and 200-day averages, their alignment, RSI and MACD). A rating summarises the chart; it is not a recommendation.
ŷRobot chart signal: Bullish, from the chart signal model.
DB analysis: AI score, fair value and forecast · Is it a bull or a bear market today? · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.